A 4-yr old male child presents with muscle weakness. His mother tells that her child has difficulty climbing stairs and getting up from the floor. On muscle biopsy, small muscle fibrils and absent of dystrophin was found. what is the diagnosis out of given options?

Explanation

## Correct Answer: D. Duchenne muscular dystrophy Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder caused by mutations in the dystrophin gene on Xp21, resulting in **absent or severely deficient dystrophin protein**. The clinical presentation in this 4-year-old boy—proximal muscle weakness (difficulty climbing stairs, rising from floor), early age of onset (typically 3–5 years), and **small muscle fibrils with absent dystrophin on biopsy**—is pathognomonic for DMD. The absence of dystrophin is the defining histological finding that distinguishes DMD from other muscular dystrophies. In DMD, dystrophin is completely absent or present in <3% of muscle fibers, whereas in Becker's muscular dystrophy (a milder allelic variant), dystrophin is present but abnormal or reduced. The proximal weakness pattern (Gower's sign, difficulty rising from floor) and early childhood onset are classic. Indian pediatric guidelines and epidemiological data confirm DMD as the most common muscular dystrophy in children, with an incidence of ~1 in 3,500 male births. Muscle biopsy showing small fibrils (myopathic pattern) with immunohistochemistry demonstrating absent dystrophin is the gold standard for diagnosis before genetic confirmation. ## Why the other options are wrong **A. Limb-girdle muscular dystrophy** — Limb-girdle muscular dystrophy (LGMD) presents with proximal weakness but is **autosomal recessive or dominant**, not X-linked. Crucially, dystrophin is **normal or present** in LGMD; the defect lies in other proteins (sarcoglycans, calpains, dysferlin). The biopsy finding of absent dystrophin rules out LGMD entirely. LGMD typically has later onset (childhood to early adulthood) and slower progression than DMD. **B. Becker's muscle dystrophy** — Becker's muscular dystrophy is also X-linked and caused by dystrophin gene mutations, but the **dystrophin protein is present but abnormal or reduced in quantity** (not completely absent). Becker's presents with milder symptoms, later onset (typically >5 years), and slower progression. The **absence of dystrophin on immunohistochemistry is incompatible with Becker's**; this finding is specific to DMD. Becker's patients retain some dystrophin function. **C. Myotonic dystrophy** — Myotonic dystrophy is an **autosomal dominant trinucleotide repeat disorder** (DMPK gene, chromosome 19), not X-linked. It presents with myotonia (delayed muscle relaxation), facial weakness, ptosis, and cataracts—**none of which are mentioned in this case**. Dystrophin is normal in myotonic dystrophy. The biopsy would show type 1 fiber atrophy and central nuclei, not the small fibrils with absent dystrophin seen here. ## High-Yield Facts - **Absent dystrophin on immunohistochemistry = DMD**, not Becker's (which shows reduced/abnormal dystrophin). - **DMD is X-linked recessive**; affects males predominantly; incidence ~1 in 3,500 male births in India. - **Proximal weakness (Gower's sign, difficulty rising from floor) in early childhood (3–5 years)** is the classic presentation of DMD. - **Myopathic pattern on EMG** (small amplitude, short duration, polyphasic potentials) and **elevated CK (>10× normal)** support DMD diagnosis. - **Wheelchair dependence by age 10–12 years** and **cardiac/respiratory complications by late teens** are typical natural history milestones in untreated DMD. - **Corticosteroids (prednisolone 0.75 mg/kg/day)** are the standard of care in India to slow progression and extend ambulation; genetic counseling for carrier females is essential. ## Mnemonics **DMD vs Becker's: The Dystrophin Rule** **D**uchenne = **D**ystrophin **D**eficient (absent); **B**ecker's = **B**etter dystrophin (present but abnormal). Use this when you see 'absent dystrophin' on biopsy—it's DMD, not Becker's. **DMD Red Flags in Children** **G**ower's sign, **R**ising difficulty, **O**nset 3–5 years, **W**eakness proximal, **S**low progression (initially). When you see a boy climbing stairs with difficulty before age 5, think DMD first. ## NBE Trap NBE often pairs "muscle weakness in childhood" with "small fibrils on biopsy" to lure students toward LGMD or myotonic dystrophy. The discriminator is the **absent dystrophin**—this single finding locks the answer to DMD and rules out all others. Students who focus only on "proximal weakness" without integrating the biopsy finding may incorrectly choose LGMD. ## Clinical Pearl In Indian pediatric practice, DMD is the most common cause of progressive muscle weakness in boys aged 3–10 years. Early recognition via CK screening and dystrophin immunohistochemistry allows timely initiation of corticosteroids, which can delay wheelchair dependence by 2–3 years—a significant quality-of-life impact for Indian families. Genetic counseling for carrier mothers is critical for family planning. _Reference: OP Ghai Pediatrics Ch. 14 (Neuromuscular Disorders); Robbins Pathology Ch. 27 (Skeletal Muscle); Harrison Principles of Internal Medicine Ch. 451 (Muscle Diseases)_